| Candy J Rowland, MSPT | |
|
1425 Potts St, Malvern, AR 72104-5291 | |
| (501) 337-7586 | |
| Not Available |
| Full Name | Candy J Rowland |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1425 Potts St, Malvern, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568513398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2552 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Candy J Rowland, MSPT 7100 Shamrock Cv, Benton, AR 72015-7598 Ph: () - | Candy J Rowland, MSPT 1425 Potts St, Malvern, AR 72104-5291 Ph: (501) 337-7586 |
News Archive
To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease.
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement today on the recent U.S. House Appropriations Labor, Health and Human Services, Education, and Related Agencies subcommittee vote to provide the Department of Health and Human Services (HHS) Inspector General, the Centers for Medicare and Medicaid Services (CMS), and the Justice Department with $561 million for programs designed to combat fraud, waste, and abuse:
A major finding, which represents an important step toward a potential cure for type 1 (insulin-dependent) diabetes, has been made by a research team at the La Jolla Institute for Allergy & Immunology (LIAI). The team, led by Matthias von Herrath, M.D., an internationally recognized expert on the molecular basis of type 1 diabetes, used a combinatorial treatment approach in laboratory mice and found it reversed recent onset type 1 diabetes in the majority of animals tested.
Facet Biotech Corporation and Bristol-Myers Squibb Company announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented today at the American Society of Hematology (ASH) 2009 Annual Meeting in New Orleans.
› Verified 2 days ago
Warrior Concierge Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 108 Hoback Ridge Rd, Malvern, AR 72104 Phone: 501-276-6929 | |
Tiffany Weston, Physical Therapist Medicare: Medicare Enrolled Practice Location: 640 Mlk Blvd, Malvern, AR 72104 Phone: 501-467-8275 Fax: 501-467-8145 | |
Source Therapy Solutions Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1721 Martin Luther King Blvd, Suite I, Malvern, AR 72104 Phone: 501-249-5354 | |
Stephanie Hoff Jones, P.T., D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 108 Hoback Ridge Rd, Malvern, AR 72104 Phone: 501-276-6929 | |
Malvern Physical Therapy & Wellness Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 720 Walco Rd, Suite 240, Malvern, AR 72104 Phone: 501-467-8275 Fax: 501-467-8145 | |
Penny Peters, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1820 W Moline St, Malvern, AR 72104 Phone: 501-337-9581 | |
Emily Berry, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 850 Henry St, Malvern, AR 72104 Phone: 501-337-1836 Fax: 501-337-7935 |